N | Mean | Median | SD | Min | Max | Wilcoxon’s p | |
---|---|---|---|---|---|---|---|
NO (μmol/L) | |||||||
Baseline samples | 173 | 261.47 | 211.80 | 192.86 | 8.28 | 1,567.20 | 0.89 |
On-treatment samples* | 51 | 237.09 | 227.10 | 140.68 | 42.69 | 606.70 | |
OPN (ng/mL) | |||||||
Baseline samples | 173 | 98.68 | 62.56 | 89.29 | 23.12 | 512.00 | 0.002 |
On-treatment samples | 51 | 75.42 | 54.72 | 76.32 | 25.44 | 507.52 | |
TGF-β1(ng/mL) | |||||||
Baseline samples | 173 | 34.24 | 20.63 | 57.07 | 0.53 | 662.21 | 0.025 |
On-treatment samples | 51 | 28.36 | 18.80 | 33.35 | 3.34 | 228.33 | |
VEGF-A (pg/mL) | |||||||
Baseline samples | 172 | 122.54 | 57.85 | 190.33 | 15.60 | 1,601.31 | <0.001 |
On-treatment samples | 51 | 46.79 | 44.80 | 21.17 | 15.60 | 130.81 |